BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24021784)

  • 1. [Correlation of hepatitis B virus X antigen expression with liver cell apoptosis].
    Li C; Wang YK; Wang CY; DU L; Zhang XH; Dong GF
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):252-6. PubMed ID: 24021784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.
    Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM
    World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
    Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
    Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis].
    Huang Y; Wu G; Wang X
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):235-8. PubMed ID: 7587601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.
    Feitelson MA; Reis HM; Liu J; Lian Z; Pan J
    Front Biosci; 2005 May; 10():1558-72. PubMed ID: 15769646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma].
    Li J; Tang ZY; Liu KD; Schroder CH
    Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different pre-S deletion patterns and their association with hepatitis B virus genotypes.
    Chen BF
    World J Gastroenterol; 2016 Sep; 22(35):8041-9. PubMed ID: 27672298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of hepatitis B x antigen as a prognostic marker in the development of hepatocellular carcinoma.
    Zhu M; London WT; Duan LX; Feitelson MA
    Int J Cancer; 1993 Oct; 55(4):571-6. PubMed ID: 8406983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.
    Feitelson MA; Reis HM; Tufan NL; Sun B; Pan J; Lian Z
    Cancer Lett; 2009 Dec; 286(1):69-79. PubMed ID: 19201080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fibronectin gene expression by hepatitis B virus x antigen.
    Norton PA; Reis HM; Prince S; Larkin J; Pan J; Liu J; Gong Q; Zhu M; Feitelson MA
    J Viral Hepat; 2004 Jul; 11(4):332-41. PubMed ID: 15230856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infection.
    Ehrmann J; Galuszková D; Ehrmann J; Krc I; Jezdinská V; Vojtések B; Murray PG; Koláo Z
    Pathol Oncol Res; 2000; 6(2):130-5. PubMed ID: 10936789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis B serum promotes apoptotic damage in human renal tubular cells.
    Deng CL; Song XW; Liang HJ; Feng C; Sheng YJ; Wang MY
    World J Gastroenterol; 2006 Mar; 12(11):1752-6. PubMed ID: 16586546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.